Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

[1]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[2]  D. Rader,et al.  Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[3]  Jennifer G. Robinson,et al.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[4]  Muin J Khoury,et al.  Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence , 2010, Genetics in Medicine.

[5]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[6]  S. Humphries,et al.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study , 2008, European heart journal.

[7]  Michael Higgins,et al.  An Electronic Health Record - Public Health (EHR-PH) System Prototype for Interoperability in 21st Century Healthcare Systems , 2005, AMIA.

[8]  Carolyn M Hutter,et al.  Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. , 2004, American journal of epidemiology.

[9]  F. Civeira,et al.  Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. , 2004, Seminars in vascular medicine.

[10]  J. Kastelein,et al.  Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. , 2004, Seminars in vascular medicine.

[11]  T. Leren,et al.  Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program. , 2004, Seminars in vascular medicine.

[12]  J. Kastelein,et al.  Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. , 2003, Archives of internal medicine.

[13]  E. Sijbrands,et al.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.

[14]  D. Bhatnagar,et al.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia , 2000, BMJ : British Medical Journal.

[15]  S. Humphries,et al.  Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study , 2000, BMJ : British Medical Journal.

[16]  N. Calonge,et al.  Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.

[17]  S. Humphries,et al.  MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths , 1996 .

[18]  Y. Christen,et al.  Genetic Approaches to Noncommunicable Diseases , 1996, Springer Berlin Heidelberg.

[19]  M. C. Leske,et al.  Comparing self-reported and physician-reported medical history. , 1994, American journal of epidemiology.

[20]  M. Leppert,et al.  Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. , 1993, The American journal of cardiology.

[21]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[22]  S. Rose.  HUMAN PERFECTIBILITY , 1984, The Lancet.

[23]  L. Solomon,et al.  The Metabolic Basis of Inherited Disease , 1979 .

[24]  J. Slack.  RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES , 1969 .

[25]  J. Slack.  Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. , 1969, Lancet.